FDA Approves New Dosing Schedule For Eli Lilly's Kisunla In Alzheimer's Treatment - Eli Lilly (NYSE:LLY)

Join us for the 2025 Walk to End Alzheimer's Kickoff!

WACO, Texas (FOX 44) - The kickoff for the Waco 2025 Walk to End Alzheimer’s Disease is Tuesday night, and you're invited! The official launch and planning for the Walk is taking place at Panera Bread, located at 2516 W Loop 340, from 4 p.m. until 9 p.m. Staff members from the local Waco Alzheimer’s Office and regional offices will be in attendance, as well as the many of the volunteers and chairperson for the 2025 Walk!  The Walk says this even…

FDA Approves Updated Label With New Dosing For Lilly's Alzheimer's Drug ...

FDA clears new, safer regimen for Lilly's Alzheimer's drug

Eli Lilly has won FDA approval for a new regimen for its Alzheimer's disease therapy Kisunla, which carries a reduced risk of side effects

Lilly gets FDA OK of modified dosing for Alzheimer’s drug

A slower ramp-up of Kisunla dosing lowers the rate of dangerous brain swelling, a risk that has made doctors reluctant to prescribe Lilly’s amyloid-busting drug.

FDA approves new dosing schedule for Lilly’s Alzheimer’s drug Kisunla

FDA approves updated label for Lilly's Kisunla (donanemab-azbt) with new dosing in early symptomatic Alzheimer's disease

/PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved a label update with a new...